Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 24:17:627-635.
doi: 10.2147/NDT.S284308. eCollection 2021.

Peripheral Polyneuropathy and Cognitive Impairment in Type II Diabetes Mellitus

Rasha Elbialy Elsharkawy  1 , Ghada Saed Abdel Azim  1 , Marwa Abdellah Osman  1 , Hend Maghraby Maghraby  2 , Rehab Abdelfattah Mohamed  2 , Eman Mahmoud Abdelsalam  2 , Eman Elshohat Ebrahem  3 , Nora Mohamed Ahmed Seliem  3
Affiliations

Peripheral Polyneuropathy and Cognitive Impairment in Type II Diabetes Mellitus

Rasha Elbialy Elsharkawy et al. Neuropsychiatr Dis Treat. .

Abstract

Background: Neuropathy is one of most common complications in diabetic patients. Diagnosis of diabetic neuropathy is essential for decreasing the rate of the disability and death. Neuron-specific enolase (NSE) is released from damaged neuronal cells and enters the blood circulation through an injured blood brain barrier. Therefore, serum NSE can reflect the damage of neurons and brain tissue.

Objective: To evaluate peripheral polyneuropathy and cognitive function in Type 2 Diabetes Mellitus (T2DM) and correlate them with NSE level as a possible biomarker of diabetic neuropathy.

Subjects and methods: Forty five T2DM patients with polyneuropathy were randomly recruited in this study compared to 45 healthy age and sex matched subjects as a control. Patients group were divided into two subgroups, 24 diabetic patients with painful peripheral neuropathy and 21 with painless peripheral neuropathy. All were subjected to clinical assessment by diabetic neuropathy symptom score, Dyck neuropathy grading, Mini-Mental State Examination (MMSE), assessment of HbA1c, NSE biomarker and neurophysiological assessment (nerve conduction study (NCS), event related potential (P300wave) and somatosensory evoked potential (SSEP) of the right median nerve).

Results: There were significant decrease in cognitive functions in diabetic patients compared to controls and a significant increase in NSE in diabetic patients. There were no significant difference between patients with painless and painful diabetic neuropathy as regard MMSE, HbA1c and NSE. There were significant correlation of P300 in diabetic patients with HbA1c and NSE.

Conclusion: Neurophysiological assessment of diabetic patients by NCS, SSEP and P300 have well evaluation of cognitive functions, painless, and painful diabetic polyneuropathy. NSE is a beneficial biomarker in diabetic patients to pick up neurological complications.

Keywords: MMSE; Mini-Mental State Examination; NSE; diabetic neuropathy; glycated hemoglobin; nerve conduction study; neuron-specific enolase.

PubMed Disclaimer

Conflict of interest statement

The authors declared no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Mean level of neuron-specific enolase (NSE) increased in diabetic patients group compared to control. Mean score of Mini-Mental State Examination (MMSE) was decreased in diabetic patients compared to control.
Figure 2
Figure 2
P300 waves increased in diabetic patients with painless neuropathy (Group 1a) compared to diabetic patients with painful neuropathy (Group 1b).
Figure 3
Figure 3
Scatter plot of the relationship between P300 and neuron-specific enolase (NSE), P<0.001.
Figure 4
Figure 4
ROC data of neuron-specific enolase (NSE) in diabetic patients vs control.
See this image and copyright information in PMC

References

    1. Ali A, Iqbal F, Taj A, Iqbal Z. Prevalence of microvascular complications in newly diagnosed patients with type 2 diabetes. Pak J Med Sci. 2013;29:899–902. doi:10.12669/pjms.294.3704 - DOI - PMC - PubMed
    1. Kiernan C. Emergence of a predictive clinical biomarker for diabetic neuropathy. J Diab. 2012;61(6):1346–1347. doi:10.2337/db12-0193 - DOI - PMC - PubMed
    1. Jianbo LI. NSE potential biomarker is closely connected to diabetic peripheral neuropathy. Diab Care. 2013;36(11):3405–3410. - PMC - PubMed
    1. Dyck P, Carter R, Litchy W. Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathy. Muscle Nerve. 2011;44:340–345. doi:10.1002/mus.22074 - DOI - PMC - PubMed
    1. Shin H, Gong H, Oh J, Paik N. Comparison between nerve conduction studies and current perception threshold test in carpal tunnel syndrome. Neurophysiol Clin. 2008;38:127–131. doi:10.1016/j.neucli.2007.12.003 - DOI - PubMed

LinkOut - more resources